---
title: "MVSS 2023: Human Acellular Vessel proves ‘safe, effective bypass conduit’ in complex CLTI cohort"
date: "2023-10-06T01:32:12.000Z"
publishedDate: "6 octobre 2023"
summary: "An investigator-sponsored clinical study conducted at the Mayo Clinic in Rochester, Minnesota, of the investigational Human Acellular Vessel (HAV) in patients with chronic limb-threatening ischemia (CLTI) was presented at the Midwestern Vascular Surgical Society (MVSS) annual meeting in Minneapolis, Minnesota (Sept. 7–9)."
importance: ""
sourceUrl: "https://vascularnews.com/mvss-2023-human-acellular-vessel-proves-safe-effective-bypass-conduit-in-complex-clti-cohort/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2023-10-06-mvss-2023-human-acellular-vessel-proves-safe-effective-bypass-conduit-in-complex-clti-cohort"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/10/Cifuentes-HAV.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/mvss-2023-human-acellular-vessel-proves-safe-effective-bypass-conduit-in-complex-clti-cohort/"
---

![MVSS 2023: Human Acellular Vessel proves ‘safe, effective bypass conduit’ in complex CLTI cohort](https://vascularnews.com/wp-content/uploads/sites/7/2023/10/Cifuentes-HAV.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/mvss-2023-human-acellular-vessel-proves-safe-effective-bypass-conduit-in-complex-clti-cohort/*

## L’essentiel

An investigator-sponsored clinical study conducted at the Mayo Clinic in Rochester, Minnesota, of the investigational Human Acellular Vessel (HAV) in patients with chronic limb-threatening ischemia (CLTI) was presented at the Midwestern Vascular Surgical Society (MVSS) annual meeting in Minneapolis, Minnesota (Sept. 7–9).

## Lien source

https://vascularnews.com/mvss-2023-human-acellular-vessel-proves-safe-effective-bypass-conduit-in-complex-clti-cohort/
